DuP-128 analogs

N/A

Report date: 2022/05/12 17:20:46
NME

Base Information

Drug NameDuP-128 analogs
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase 1 inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase 1Acyl coenzyme A:cholesterol acyltransferase 2
Therapy Area/IndicationsHypercholesterolemiaAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesDupont Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDupont Pharma
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A